Ebola Drugs Take Center Stage In Review Voucher Bill, But Real Value May Be Harmonization
Executive Summary
Along with adding Ebola to list of disease treatments eligible for tropical disease priority review voucher, bill moving through Congress would cut notification time required before redemption.
You may also be interested in...
Sanofi Diabetes Franchise Could Get Boost From Retrophin’s Voucher
Priority review ticket might be used on Type 2 diabetes combo LixiLan, expected to be filed later this year.
Ebola Vaccines: FDA Advisory Committee Convenes As Outbreak Recedes
Challenge of testing vaccines when infections seem to be coming under control is among potential issues for May 12 meeting.
Priority Review Vouchers Could Be Used Frequently Next Year
FDA requests enough pediatric rare disease priority review voucher user fees to fund three redemptions in fiscal year 2016.